P152 The role of FDG-PET/CT in follow-up of children with lymphoma
✍ Scribed by M. Csóka; B. Szatmáry; J. M¨uller; H. Erlaky; I. Haltrich; G. Kovács
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 49 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
✦ Synopsis
have transfusion necessity, after the 3 month interval from the beginning of the therapy; in 14% of patients Erythropoietin was used to correct the anemic syndrome. The dosage was 10000 IU 3 times per week subcutaneous. Since no severe granulocytopenia cases were reported the administration of GM-CSF and G-CSF was inopportune.
Our study deserves to continue on larger groups of patients to confirm or disconfirm our initial conclusions.
📜 SIMILAR VOLUMES
F 18 -2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) has become a well established tool in staging and assessing therapy response in lymphoma. Incidental thyroid uptake on PET is not uncommon and can pose a diagnostic and management challenge. We retrospectively evaluate the pre
## Background: Positron emission tomography (pet) is a nuclear imaging technique providing noninvasive, three-dimensional, whole-body, quantitative images. the primary use of pet is in tumor detection and staging. more recently, it has been shown to be of value in assessing patients with inflammato